Search

Inmode Ltd

Avatud

SektorTervishoid

15.31 -0.71

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

15.14

Max

15.53

Põhinäitajad

By Trading Economics

Sissetulek

-15M

12M

Müük

-22M

82M

P/E

Sektori keskmine

11.306

60.149

Aktsiakasum

0.25

Kasumimarginaal

14.097

Töötajad

660

EBITDA

-17M

15M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+10.68% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-36M

871M

Eelmine avamishind

16.02

Eelmine sulgemishind

15.31

Uudiste sentiment

By Acuity

50%

50%

156 / 340 Pingereas Healthcare

Inmode Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. juuli 2026, 19:26 UTC

News

InMode Ltd faces scrutiny from Bronstein, Gewirtz & Grossman, LLC, over governance issues, contributing to a decline in its stock price since Friday's close.

Võrdlus sarnastega

Hinnamuutus

Inmode Ltd Prognoos

Hinnasiht

By TipRanks

10.68% tõus

12 kuu keskmine prognoos

Keskmine 17 USD  10.68%

Kõrge 19 USD

Madal 15 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Inmode Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

1

Osta

4

Hoia

0

Müü

Sentiment

By Acuity

156 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat